Light therapy for energy and stress in type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study tests whether light therapy can improve how cells make energy and reduce stress on the body, in both healthy people and people with type 1 diabetes. If you join, you may learn if this approach helps your body function better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 12 to 40 years old.
- You have been diagnosed with type 1 diabetes and are on insulin therapy.
- Your diabetes was diagnosed at least 1 year ago.
- You are not pregnant, do not smoke, and have no kidney or liver problems.
- You have not used vitamin C, vitamin E, or other antioxidant supplements in the past month.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new treatment called RGB-5088 in people with type 1 diabetes. It aims to see if the treatment is safe and if it helps control blood sugar.
This trial tests whether shining a special light on the body (called photobiomodulation) can help improve blood sugar control in people with type 2 diabetes. It may be a gentle addition to your current diabetes care.
This study tests a non-invasive treatment called biophoton therapy (using light energy) to see if it can help control blood sugar in people with type 2 diabetes. If you qualify, you would receive this therapy and the research team would monitor your progress.
This study looks at ways to better recognize and manage the emotional stress that can come with type 1 diabetes. It tests a new approach to care that includes training for your healthcare team and support from family or friends.
This study tests a treatment that uses a patient's own immune cells to help the body make more insulin. It may help people with type 1 diabetes manage their blood sugar better.
This study tests an experimental medicine called RGB-5088 for people with type 2 diabetes who are already using insulin. The goal is to see if it can safely improve blood sugar control when added to your current diabetes management.
Hear when a new Healthy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.